KTTAW stock · TRMB stock

KTTAW vs TRMB

Pasithea Therapeutics Corp. Warrant (KTTAW) versus Trimble Inc (TRMB) — a side-by-side from cached financials, not a winner call.

Pasithea Therapeutics Corp. Warrant (KTTAW) is a biotechnology company listed on US.

Trimble Inc (TRMB) is a scientific & technical instruments company listed on NASDAQ.

KTTAW does not have a complete income-statement cache yet.

Latest reported TRMB revenue for 2026-07-03 was $1.91B. Net income was -$372.8M. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.

KTTAW currently screens at market cap $0. TRMB currently screens at market cap $11.39B and trailing P/E 25.6.

Not investment advice. Open the KTTAW and TRMB stock pages for the full models.

Not investment advice.

Popular Stock Comparisons